Clinical Trial Update: Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria [NA]

View source ↗

Summary

A completed clinical trial evaluated the effect of adding nebulized amikacin for ventilator-associated pneumonia caused by Gram-negative bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Amikacin (amikacin)

Snippet

Sponsor: Thammasat University | Conditions: Pneumonia, Ventilator-Associated | NA | Status: COMPLETED